- Coles Group’s net income for FY 2024 is A$1.12 billion, increasing by 1.8% year-over-year, beating the estimate of A$1.07 billion.
- Sales revenue from continuing operations stands at A$43.57 billion, up by 7.6% year-over-year, surpassing the estimate of A$43.49 billion.
- Supermarket sales are reported at A$39.04 billion, showing a 6.2% year-over-year growth, slightly below the estimate of A$39.06 billion.
- The final dividend per share is A$0.32, higher than the previous year’s A$0.30.
- Earnings before interest and taxes (Ebit) from continuing operations total A$2.06 billion, up by 11% year-over-year, exceeding the estimate of A$1.98 billion.
- Supermarkets’ Ebit is A$2.02 billion, recording a 14% year-over-year increase, outperforming the estimate of A$1.84 billion.
- Analysts’ ratings include 6 buys, 8 holds, and 2 sells.
A look at Coles Group Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 3 | |
| Growth | 4 | |
| Resilience | 2 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Looking ahead, Coles Group’s long-term outlook appears promising based on its Smartkarma Smart Scores. The company scores well in growth and momentum, indicating a positive trajectory in terms of expansion and market performance. Additionally, Coles Group demonstrates strength in dividend payout, providing potential returns for investors. However, there are areas for improvement, with lower scores in value and resilience suggesting some challenges in terms of underlying asset value and ability to withstand economic downturns. Overall, with its focus on supermarkets, department stores, and a wide range of product offerings in Australia and New Zealand, Coles Group continues to position itself as a key player in the retail sector.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
